資料載入中.....
|
請使用永久網址來引用或連結此文件:
http://ir.cmu.edu.tw/ir/handle/310903500/30181
|
| 題名: | Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma |
| 作者: | Lin, JC;Jan, JS;Chen, KY;Hsu, CY;Liang, WM;Wang, WY |
| 貢獻者: | 醫學院醫學系;Taichung Vet Gen Hosp, Dept Radiat Oncol, Taichung 407, Taiwan;Natl Yang Ming Univ, Coll Med, Inst Clin Med, Taipei 112, Taiwan;China Med Coll, Sch Med, Taichung, Taiwan;Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan;Taichung Vet Gen Hosp, Dept Otorhinolaryngol, Taichung, Taiwan;China Med Coll, Dept Publ Hlth, Taichung, Taiwan;Hung Kuang Inst Technol, Dept Basic Med, Taichung, Taiwan |
| 日期: | 2003 |
| 上傳時間: | 2010-09-24 14:50:42 (UTC+8) |
| 出版者: | JOHN WILEY & SONS INC |
| 摘要: | We conducted a prospective 3-yr clinical study comparing deferiprone (L1) with desferrioxamine (DFX). The therapeutic efficacy and potential side-effects on cardiac and/or hepatic systems of thalassemia patients were assessed by left ventricular ejection fraction, T2-weighted magnetic resonance imaging, and biochemical parameters. In both groups, levels of serum ferritin decreased significantly, and the hepatic function improved notably. Besides decrement of iron, no marked pathohistological changes were observed in the liver biopsies. These results indicated that for patients who failed to respond to DFX treatment, the use of L1 to remove excess iron deposition is recommended. |
| 關聯: | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 25(6):438-447 |
| 顯示於類別: | [醫學系] 期刊論文
|
在CMUR中所有的資料項目都受到原著作權保護.
|
